Inventiva SA
PAR:IVA

Watchlist Manager
Inventiva SA Logo
Inventiva SA
PAR:IVA
Watchlist
Price: 2.76 EUR 1.66%
Market Cap: 264m EUR

P/E
Price to Earnings

-2.5
Current
-3.4
Median
21.6
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-2.5
=
Market Cap
264m EUR
/
Net Income
-104.2m EUR
Market Cap P/E
FR
Inventiva SA
PAR:IVA
264m EUR -2.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -172 668.6
US
Abbvie Inc
NYSE:ABBV
378.6B USD 89.3
US
Amgen Inc
NASDAQ:AMGN
170.3B USD 41.6
US
Gilead Sciences Inc
NASDAQ:GILD
139.9B USD 291.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
132B USD -246.5
US
Epizyme Inc
F:EPE
94.1B EUR -494.8
AU
CSL Ltd
ASX:CSL
119.9B AUD 27.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.4B USD 16.9
US
Seagen Inc
F:SGT
39.3B EUR -57.3
NL
argenx SE
XBRU:ARGX
33.5B EUR 43.9
Earnings Growth PEG
FR
Inventiva SA
PAR:IVA
Average P/E: 85.2
Negative Multiple: -2.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -172 668.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
89.3
88%
1
US
Amgen Inc
NASDAQ:AMGN
41.6
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
291.4
185%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -246.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -494.8 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
11%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.3 N/A N/A
NL
argenx SE
XBRU:ARGX
43.9
19%
2.3

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-2.7
2-Years Forward
P/E
-3.6
3-Years Forward
P/E
-3.8